GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Rhea-AI Summary

GRAIL (Nasdaq: GRAL) granted inducement equity awards in the form of restricted stock units (RSUs) covering an aggregate of 34,350 shares of common stock to 56 newly hired non-executive employees.

The RSUs, issued under GRAIL's Inducement Equity Incentive Plan pursuant to Nasdaq Listing Rule 5635(c)(4), vest over about four years, with 25% vesting on May 31, 2027 and annually thereafter, subject to continued employment.

AI-generated analysis. Not financial advice.

Key Figures

Current price: $69.04 Inducement RSU shares: 34,350 shares Employees receiving RSUs: 56 employees +5 more

8 metrics

Current price $69.04 Pre-news trading level

Inducement RSU shares 34,350 shares Aggregate RSUs granted to new non-executive employees

Employees receiving RSUs 56 employees Recently hired non-executive staff

RSU vesting period Approximately 4 years Overall RSU vesting schedule

Initial vesting tranche 25% on May 31, 2027 First RSU vesting date and proportion

52-week high $118.84 52-week trading range high

52-week low $29.95 52-week trading range low

Market cap $2,959,528,253 Pre-news equity value

Market Reality Check

Price: $69.03 Vol: Volume 818,702 is 1.34x t...

normal vol

$69.03 Last Close

Volume Volume 818,702 is 1.34x the 20-day average of 610,291, indicating elevated trading activity ahead of this HR-focused update. normal

Technical Shares at 69.04 are trading just above the 200-day MA of 68.9 and about 41.9% below the 52-week high of 118.84.

Peers on Argus

GRAL is up 2.63% with elevated volume, while peers show mixed, mostly positive m...

GRAL is up 2.63% with elevated volume, while peers show mixed, mostly positive moves: TWST +6.27%, NEOG +2.93%, OPK +1.57%, NEO +0.32%, and CDNA -0.97%, suggesting stock-specific dynamics rather than a coordinated sector move.

Common Catalyst Some peers, such as TWST, reported conference participation today, but GRAL’s news relates to employee inducement equity grants rather than events or clinical/financial catalysts.

Historical Context

5 past events · Latest: May 21 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
May 21	Conference presentation notice	Neutral	-1.0%	Jefferies healthcare conference presentation announcement with webcast availability.
May 05	Quarterly earnings results	Positive	+15.3%	Q1 2026 revenue growth, Galleri volume gains, and FDA PMA review acceptance.
Apr 30	Conference participation news	Neutral	-0.8%	BofA Securities health care conference presentation scheduling and webcast details.
Apr 22	Earnings date announcement	Neutral	-3.7%	Announcement of timing for Q1 2026 results release and conference call.
Apr 21	Clinical data presentation	Positive	+1.8%	Plan to present large NHS-Galleri and PATHFINDER 2 datasets at ASCO 2026.

Pattern Detected

Earnings and major data updates have previously coincided with strong positive moves, while routine conference or scheduling announcements often saw modest declines.

Recent Company History

Over the last few months, GRAIL reported strong Q1 2026 results on May 5, 2026, with revenue growth that coincided with a 15.35% price gain, and announced large NHS-Galleri and PATHFINDER 2 datasets on April 21, 2026, followed by a 1.77% rise. In contrast, routine conference and earnings-date notices on April 22, April 30, and May 21, 2026 were followed by modest pullbacks between -0.77% and -3.71%. Today’s inducement RSU grants fit the pattern of administrative updates rather than major commercial or clinical catalysts.

Market Pulse Summary

This announcement details inducement grants of 34,350 RSU-based shares to 56 newly hired non-executi...

Analysis

This announcement details inducement grants of 34,350 RSU-based shares to 56 newly hired non-executive employees under Nasdaq Listing Rule 5635(c)(4), vesting over roughly four years with 25% vesting on May 31, 2027. It underscores ongoing hiring but does not change previously disclosed fundamentals, such as Q1 2026 revenue and major clinical programs. Investors may watch future earnings, regulatory milestones, and large trial readouts for more material catalysts.

Key Terms

restricted stock units, rsus, nasdaq listing rule 5635(c)(4), inducement equity incentive plan, +1 more

5 terms

restricted stock units financial

"granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

rsus financial

"in the form of restricted stock units ("RSUs") underlying an aggregate of 34,350 shares"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

nasdaq listing rule 5635(c)(4) regulatory

"agreement in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

inducement equity incentive plan financial

"awards were granted under GRAIL's Inducement Equity Incentive Plan and related form"

An inducement equity incentive plan is a program that grants employees or executives company shares or stock options to motivate and reward their work, often as a way to attract new talent. It aligns their interests with the company's success, encouraging them to contribute to long-term growth. For investors, such plans can influence a company's stock performance and overall financial health by motivating key personnel.

restricted stock award agreement financial

"Inducement Equity Incentive Plan and related form of restricted stock award agreement in"

A restricted stock award agreement is a legal contract that grants someone company shares that are subject to limits — for example, they may only become fully owned after working at the company for a set time, meeting performance goals, or otherwise satisfying conditions. For investors, these agreements matter because they shape insider incentives, future share dilution when restrictions lift, and company compensation costs; think of it like a gift locked in a box that opens only after certain conditions are met.

AI-generated analysis. Not financial advice.

MENLO PARK, Calif., May 27, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 34,350 shares of GRAIL's common stock to 56 recently hired non-executive employees as an inducement material to their acceptance of employment with GRAIL. The employment inducement awards were granted under GRAIL's Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635(c)(4).

The RSUs vest over an approximately four year period, with 25% of the award vesting May 31, 2027, and on each one year anniversary of those respective dates thereafter, subject to continued employment with GRAIL (or any successor to or subsidiary of the Company) through the vesting dates.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302783559.html

SOURCE GRAIL, Inc.

FAQ

What inducement equity awards did GRAIL (GRAL) announce on May 27, 2026?

GRAIL announced inducement grants of RSUs covering 34,350 shares of common stock to 56 newly hired non-executive employees. According to GRAIL, these awards were granted as material inducements to accept employment under its Inducement Equity Incentive Plan.

Why did GRAIL (GRAL) grant 34,350 RSU shares to new employees?

GRAIL granted 34,350 RSU shares as inducement awards to 56 recently hired non-executive employees. According to GRAIL, the RSUs are intended as material incentives for these individuals to enter into employment, in line with Nasdaq Listing Rule 5635(c)(4).

How do the GRAIL (GRAL) inducement RSUs granted in May 2026 vest?

The GRAIL inducement RSUs vest over approximately four years. According to GRAIL, 25% of each award vests on May 31, 2027, with additional 25% tranches vesting on each one-year anniversary thereafter, subject to continued employment with GRAIL or its affiliates.

Who is eligible for GRAIL (GRAL) inducement equity awards under Nasdaq Rule 5635(c)(4)?

GRAIL’s inducement equity awards are granted only to individuals not previously employed by GRAIL, or rehires after a bona fide break. According to GRAIL, these RSUs serve as material inducements for such individuals to enter into employment under Nasdaq Listing Rule 5635(c)(4).

How many employees received GRAIL (GRAL) inducement RSUs in May 2026 and in what roles?

Fifty-six recently hired non-executive employees received GRAIL inducement RSUs. According to GRAIL, these equity awards are tied specifically to new non-executive hires, aligning long-term compensation with company performance while complying with Nasdaq Listing Rule 5635(c)(4) requirements.